PAX® – Pet Allergy Xplorer – Serum Test
PAX is the first quantitative multiplex macroarray specifically designed for companion animals that...
Lue lisää
Artuvetrin® Therapy is a licensed immunotherapy in Europe. It treats the root cause of the allergy and reduces the symptoms.
Artuvetrin® Therapy is a licensed immunotherapy in Europe. It treats the root cause of the allergy and reduces the symptoms. Artuvetrin Therapy® is tailored specifically to the individual patient. After determining what the dog, cat or horse is allergic to using our allergy tests, the allergy can be kept under control. Symptoms are greatly reduced and potentially eliminated. This therapy has proven efficacy (75%) and safety, and therefore can be given over long periods. Artuvetrin® Therapy works by giving repeated doses of allergens that stimulate an immune response and lead to the build-up of immunological tolerance. It is the only treatment that alters the course of an allergic disease while also controlling the symptoms. Compliance with the allergy treatment plan is key to success, and will accelerate recovery and allergy relief.
Artuvetrin® Therapy is administered subcutaneously at increasing doses and increasing intervals to a maximum of 1.0 ml every 4 weeks. The first dose is 0.2 ml, and this is gradually increased to a maximum of 1.0 ml, with longer intervals between each dose. When a dose of 1.0 ml is reached, after 12 weeks, then a fixed dose of 1.0 ml is administered on a monthly basis. In some cases, this treatment schedule is too fast for the patient. In such cases, it is possible to deviate from the standard schedule.
Allergy is a chronic disease so the treatment must continue for the entire lifetime of the patient. A vial of Artuvetrin lasts 10 months, meaning a new vial of immunotherapy is needed every 10 months to continue treatment and to ensure adequate relief of symptoms.
In some cases deviation from the schedule is recommended. For example, if the patient’s symptoms start or worsen immediately after an injection, then subsequent volumes can be adjusted lowered. Symptomatic medication can also be given, as required, to alleviate symptoms and calm the skin. Another example is when symptoms return 1–2 weeks before the next injection. This means the interval is too long, thus the timing can be adjusted to, for example, 0.8 ml every 3 weeks or 0.5 ml every 2 weeks. Adjusting the interval is only recommended if the patient was already on the maintenance dose (that is, 1 ml every 4 weeks). Our allergy experts will advise on any adjustments or specific cases, contact us here.
Artuvetrin® Therapy is a licensed immunotherapy in Europe. It treats the root cause of the allergy and reduces the symptoms. Artuvetrin Therapy® is tailored specifically to the individual patient. After determining what the dog, cat or horse is allergic to using our allergy tests, the allergy can be kept under control. Symptoms are greatly reduced and potentially eliminated. This therapy has proven efficacy (75%) and safety, and therefore can be given over long periods. Artuvetrin® Therapy works by giving repeated doses of allergens that stimulate an immune response and lead to the build-up of immunological tolerance. It is the only treatment that alters the course of an allergic disease while also controlling the symptoms. Compliance with the allergy treatment plan is key to success, and will accelerate recovery and allergy relief.
Artuvetrin® Therapy is administered subcutaneously at increasing doses and increasing intervals to a maximum of 1.0 ml every 4 weeks. The first dose is 0.2 ml, and this is gradually increased to a maximum of 1.0 ml, with longer intervals between each dose. When a dose of 1.0 ml is reached, after 12 weeks, then a fixed dose of 1.0 ml is administered on a monthly basis. In some cases, this treatment schedule is too fast for the patient. In such cases, it is possible to deviate from the standard schedule.
Allergy is a chronic disease so the treatment must continue for the entire lifetime of the patient. A vial of Artuvetrin lasts 10 months, meaning a new vial of immunotherapy is needed every 10 months to continue treatment and to ensure adequate relief of symptoms.
In some cases deviation from the schedule is recommended. For example, if the patient’s symptoms start or worsen immediately after an injection, then subsequent volumes can be adjusted lowered. Symptomatic medication can also be given, as required, to alleviate symptoms and calm the skin. Another example is when symptoms return 1–2 weeks before the next injection. This means the interval is too long, thus the timing can be adjusted to, for example, 0.8 ml every 3 weeks or 0.5 ml every 2 weeks. Adjusting the interval is only recommended if the patient was already on the maintenance dose (that is, 1 ml every 4 weeks). Our allergy experts will advise on any adjustments or specific cases, contact us here.
PAX is the first quantitative multiplex macroarray specifically designed for companion animals that...
Lue lisää
PAX is the first quantitative multiplex macroarray specifically designed for companion animals that...
Lue lisää
PAX® is the first quantitative multiplex macroarray specifically designed for horses that tests for...
Lue lisää